Amryt, Aegerion sign expanded deal for Lojuxta capsules
Amryt estimates there may be up to 450 additional patients who could benefit from treatment with Lojuxta across the countries covered by the extended agreement, representing an increase
AscellaHealth has acquired CHAPPER healthcare, a specialty pharmaceutical wholesaler, distributor and services provider, for undisclosed amount.
The specialty pharmaceutical company had submitted a new drug application, seeking approval for Tlando as TRT for adult males with conditions caused by deficiency of endogenous testosterone (hypogonadism). Lipocine